Advisory Commitees at FDA: The Hinchey Amendment and 'Conflict of Interest' Waivers
35 Pages Posted: 20 Feb 2013
Date Written: 2006
Congress was in 2006 considering an amendment that would prevent the agency from using appropriated funds to waive certain conflicts of interest identified by members of its advisory committees. This article opposed the change in the law, arguing that it would undermine congressional efforts in 1962 and 1989 to carefully balance the goals of attracting qualified experts and protecting agency decisionmaking. It also argued that the change was unnecessary given how conflicts were managed at FDA. It suggested following the recommendations from organizations like the OIG and GAO to improve the process at the agency level. Although the law has been amended several times since this article was written, the underlying policy debate remains live.
Keywords: advisory committees, FDA, conflicts of interest
Suggested Citation: Suggested Citation